TABLE 1.
WT |
Ldlr−/− |
|||||
NP2 | HF | HFHC-OO | HFHC-MO | HFHC-OO | HFHC-MO | |
Body weight,3 g | 28 ± 2a | 45 ± 4b | 43 ± 1b | 39 ± 2b | 40 ± 5b | 40 ± 5b |
Plasma variables4 | ||||||
Glucose, mmol/L | 6.0 ± 1.0 | 9.3 ± 2.7 | 8.3 ± 2.8 | 5.6 ± 0.7 | 11.9 ± 4.6 | 11.0 ± 4.6 |
TG,56 mg/dL | 120 ± 44a | 90 ± 16a | 66 ± 27a | 106 ± 25a | 352 ± 141b | 185 ± 82a |
Cholesterol,35 mg/dL | 52 ± 21a | 108 ± 46a | 138 ± 66b | 81 ± 6a | 957 ± 252b | 599 ± 145b |
Apo B,56 mg/dL | 11 ± 2a | 14 ± 2a | 15 ± 4a | 14 ± 2a | 160 ± 70b | 50 ± 21a |
Apo CIII,56 mg/dL | 13 ± 3a | 13 ± 7a | 10 ± 4a | 8 ± 2a | 21 ± 6b | 11 ± 6a |
NEFA,56 mEq/ml | 0.8 ± 0.2a | 0.7 ± 0.2a | 0.6 ± 0.1a | 0.7 ± 0.3a | 1.5 ± 0.6b | 0.9 ± 0.4a |
β-Hydroxybutyrate,5 mmol/L | 1.4 ± 0.3a | 1.3 ± 0.4a | 1.5 ± 0.3a | 1.7 ± 0.2a | 2.9 ± 0.8b | 2.6 ± 0.5b |
ALT,356 U/L | 4 ± 1a | 19 ± 10b | 20 ± 11b | 8 ± 2b | 38 ± 9c | 21 ± 16b,c |
AST,356 U/L | 10 ± 2a | 18 ± 2a | 30 ± 12b | 13 ± 2a | 56 ± 1c | 27 ± 12b |
Liver variables | ||||||
Weight, g | 1.0 ± 0.1 | 1.6 ± 0.5 | 1.9 ± 0.5 | 1.2 ± 0.1 | 2.0 ± 0.6 | 1.6 ± 0.4 |
% Body weight3 | 3.6 ± 0.1a | 3.4 ± 1.0a | 4.5 ± 1.2b | 3.0 ± 0.2a | 4.8 ± 0.9b | 3.9 ± 0.7a |
TG,37 μg/mg | 51 ± 23a | 157 ± 88b | 141 ± 63b | 72 ± 15a | 129 ± 13b | 64 ± 26a |
Cholesterol,3568 μg/mg | 7 ± 1a | 6 ± 2a | 8 ± 1a | 8 ± 1a | 17 ± 3b | 10 ± 5a |
Values are means ± SD; = 8/treatment group. Labeled means in a row with superscripts without a common letter differ, P < 0.05. ALT, alanine aminotransferase; AST, aspartate aminotransferase; HF, high-fat; HFHC-MO, high-fat–high-cholesterol with olive oil supplemented with menhadin oil; HFHC-OO, high-fat–high-cholesterol with olive oil; NEFA, nonesterified fatty acid; NP, nonpurified; WT, wild-type.
NP −/− mice were used as the control group.
Two-way ANOVA diet effect, < 0.05.
To convert from mg/dL to g/L, multiply by 0.0113 for TG and 0.02586 for cholesterol. To convert from mg/dL to g/L, multiply by 0.01 for apo B and apo CIII. To convert from mEq/mL to mEq/L, multiply by 1000 for NEFA.
Two-way ANOVA genotype effect, < 0.05.
Two-way ANOVA diet × gene interaction effect, < 0.05.
Data are expressed as g TG/mg protein (liver); to convert from μg/mg to mmol/g, multiply by 0.00113.
Data are expressed as g cholesterol/mg protein (liver); to convert from μg/mg to mmol/g, multiply by 0.002586.